| Code | 42154 | ||||||||||
| MA number | 18/0290/04-S | ||||||||||
| Product Form: | tbl plg 60x500 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Merck Santé s.a.s, France | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 13.12.2004 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Glucophage XR_07.2022.pdf
|
| SPC: |
SPC_Glucophage XR_03.2023.pdf
|
| Safety feature | Yes |
| Data update: | 02.11.2021 |
